From: Decreased expression of CDH1 or CTNNB1 affects poor prognosis of patients with esophageal cancer
 |  | No. of patients (n = 86) |  |
---|---|---|---|
Characteristics | Case | CDH1(+)/CTNNB1(+) | p value |
Age at surgery | Â | Â | Â |
 <65 years | 50 | 14 |  |
 >65 years | 36 | 5 | 0.119 |
Gender | Â | Â | Â |
 Male | 69 | 17 |  |
 Female | 17 | 2 | 0.252 |
Tumor status | Â | Â | Â |
 T1 | 17 | 8 |  |
 T2 | 8 | 5 |  |
 T3 | 37 | 2 |  |
 T4 | 24 | 4 |  |
 T1 vs T2–4 |  |  | 0.006 |
Lymph node status | Â | Â | Â |
 N0 | 18 | 8 |  |
 N1 | 68 | 11 |  |
 N0 vs N1 |  |  | 0.010 |
Pathological stage | Â | Â | Â |
 I | 13 | 6 |  |
 II | 11 | 5 |  |
 III | 28 | 3 |  |
 IV | 34 | 5 |  |
 I–II vs III–IV |  |  | 0.001 |
Lymphatic invasion | Â | Â | Â |
 Negative | 16 | 9 |  |
 Positive | 54 | 7 |  |
 Unknown | 16 |  | 0.003 |
Blood vessel invasion | Â | Â | Â |
 Negative | 30 | 11 |  |
 Positive | 40 | 5 |  |
 Unknown | 16 |  | 0.020 |